TEANECK, N.J., May 4, 2012 /PRNewswire/ -- Herborium Group,
Inc., (PINKS. HBRM) www.herborium.com, a Botanical
Therapeutics® company, reports today continuing progress with
its key strategic initiatives.
The company is progressing through the negotiating phase with
China Health Resource Inc. regarding a potential acquisition. Both,
Herborium Group and China Resource continue to work diligently
towards a successful transaction.
Herborium's partnership with KAMASUTRA (USA), LLC to commercialize their unique
vodka product containing Herborium's proprietary herbal formula
derived from the Company's sexual health formulations, has
moved into the introductory marketing phase with the digital
marketing plan to be initiated in June 2012. Market share for
vodka in the US is $4.8 Billion in
annual sales with both on premise and home consumption on the
rise. KAMASUTRA (USA) LLC is
the US partner of the German Bismarck Premium Brands GmbH
www.bismarck.de and
http://www.bismarck.de/kamasutra/englisch/kamasutra_ginseng_vodka.html.
The market for pharmaceutical sexual health products is over
$3.2 billion worldwide. The market
for natural sexual health products is estimated to be over
$1.5 billion, and growing.
Dr. Agnes P. Olszewski, CEO of
Herborium, recently completed the National Publicity Summit in
New York City (April 25-29, 2012). The Company is looking
forward to multiple media exposure opportunities resulting from
this Summit that shall greatly elevate
Herborium's public awareness.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company,
focuses on developing, licensing, and marketing proprietary,
botanical based medicinal products to consumers and healthcare
professionals. The Company uses clinical validation to establish
and maintain a differential advantage. The company markets its
products in the US and Europe. For
more information, please visit www.herborium.com and
www.acnease.com.
One of our most important responsibilities is to communicate
with shareholders in an open and direct manner. Comments are based
on current management expectations, and are considered
"forward-looking statements," generally preceded by words such as
"plans," "expects," "believes," "anticipates," or "intends." We
cannot promise future returns. Our statements reflect our best
judgment at the time, and we disclaim any obligation to update or
alter forward-looking statements as the result of new information
or future events. The Company urges investors to review the risks
and uncertainties contained within its filings with the OTC Markets
and/or Securities and Exchange Commission.
For more information please inquire:
Investorsrelations@herborium.com
SOURCE Herborium Group, Inc.